BioCentury | May 25, 2018
Product R&D

Peptides step up

...Davies, UT Austin Davies’ technology, dubbed Surface Localized Antimicrobial Display (SLAY), has been licensed to Anexigen Inc....
...of Inflazome Ltd., a company targeting the inflammasome for chronic diseases. Companies and Institutions Mentioned Anexigen Inc....
Items per page:
1 - 1 of 1
BioCentury | May 25, 2018
Product R&D

Peptides step up

...Davies, UT Austin Davies’ technology, dubbed Surface Localized Antimicrobial Display (SLAY), has been licensed to Anexigen Inc....
...of Inflazome Ltd., a company targeting the inflammasome for chronic diseases. Companies and Institutions Mentioned Anexigen Inc....
Items per page:
1 - 1 of 1